Relapse and immune reconstitution syndrome are difficult to distinguish in HIV-infected patients treated with antiretroviral therapy (ART). We report on a 26-year-old HIV-infected male (CDC C3) with hearing loss on the right side 2 months after discontinuing secondary prophylaxis for cryptococcal meningitis. CD4 cell counts had increased from 32/µl to stable counts > 200/µl for the preceding 6 months on ART but HIV replication was not fully suppressed (7,000 copies/ ml). Magnetic resonance imaging identified lesions at the origin of the right cranial nerve VIII. Lumbar puncture revealed monocytic pleocytosis, slightly increased protein, but normal glucose and lactate levels, negative microbiological studies. Fluconazole was restarted and a new ART regimen was started in order to fully suppress HIV replication. Clinical and radiological signs were reversible during follow-up, and secondary prophylaxis was stopped after 6 months without adverse events. We review 26 published cases of cryptococcal infections with immune reconstitution syndrome and highlight the distinguishing features.
Introduction
The discontinuation of secondary prophylaxis for cryptococcal meningitis is considered safe in HIV-infected patients on highly active antiretroviral therapy (ART) with stable CD4 cell counts > 100 cells/µl. This is supported by data from prospective studies [1] , cohort studies [2] and summarized in current guidelines [3] . However, despite clinical success and improved CD4 counts, paradoxical worsening of the clinical condition has been observed in some cases. The differential diagnosis includes relapse or immune reconstitution syndrome, which are difficult to distinguish from one another [4, 5] .
Case Report
A 26-year-old male from Thailand presented with headache and fever to our outpatient department. Cryptococcal meningitis and pneumonia was diagnosed as well as HIV-1 infection CDC C3 (CD4 cell counts of 32/µl; HIV viral load of 89,000 copies/ml [4.9 log 10]). Cryptococcus neoformans antigen was positive in blood (1:1,024). Computer scan of the neurocranium was unremarkable. In the cerebrospinal fluid (CSF), pleocytosis with 507/µl polymorphs, elevated lactate (3.4 mmol/l), elevated protein (747 mg/l) and C. neoformans was identified by culture. The patient was treated with amphotericin-B and flucytosine. The clinical condition improved, and antigen titers decreased. Secondary prophylaxis with fluconazole 400 mg daily was administered as well as trimethoprim/sulfamethoxazole (TMP/SMX) three times weekly as primary prophylaxis for Pneumocystis carinii (jiroveci). ART was initiated consisting of stavudine, lamivudine and nelfinavir ( Figure 1A ). The HIV-RNA viral load decreased by 2 log 10 and CD4 cell counts increased to 234/µl over the following 6 months. However, HIV replication was sub-optimally suppressed with viral loads around 2,000 copies/ml. ART was switched to didanosine, lamivudine and nevirapine but without significant improvement. After 9 months of stable CD4 cell counts above 200/µl, secondary prophylaxis with fluconazole was stopped ( Figure 1A) . Two months later, the patient presented with sudden hearing loss on the right side. The clinical examination was otherwise unremarkable and there was no evidence of vertigo. The audiogramm revealed right-sided central hearing loss at 1,000 Hz. contrast enhancing lesions with edema in the left and right cortex and a major lesion in the right cerebellum near the root of the eighth cranial nerve which also emerged in T2 weigted imaging ( Figure 1B) . In the CSF, monocytic pleocytosis (16/µl), low lactate (1.3 mmol/l), low glucose (2.9 mmol/l) and normal protein levels (480 mg/l) were detected. Bacterial and fungal culture remained negative. Also, negative results were obtained for cryptococcal antigen, cysticercosis antibodies, and PCR studies specific for M. tuberculosis, cytomegalovirus, polyomavirus JC, Toxoplasma gondii, and Epstein-Barr virus. The differential diagnosis included relapsing cryptococcal infection or immune reconstitution syndrome. Fluconazole was restarted (400 mg/day). HIV resistance testing was performed and ART was changed accordingly to zidovudine, didanosine and lopinavir/ ritonavir. The HIV-RNA viral load dropped under the detection limit ( Figure 1A ). Six weeks later, hearing loss was unchanged, but painful cervical lymphadenopathy developed. Biopsy of a cervical lymph node showed granulomas with cryptococci ( Figure 1D ). Cultures from lymph tissue remained negative, but Cryptococcus antigen was detectable in lymph node extracts. After 3 months, hearing improved and decreasing lesion intensity was noted in the MRI ( Figure 1C ). After 12 months, the CD4 cell counts measured 392/µl and the HIV-RNA viral load remained < 50 copies/ml. Fluconazole was discontinued and no signs of relapse occurred during a followup of 30 months. Audiogram confirmed a near complete recovery.
Discussion
Central neurological symptoms (central hearing loss) and extensive MRI lesions were unexpected in view of adequate antimicrobial therapy and stable CD4 cell counts above 200/µL for more than 6 months. Although we could not diagnose ongoing cryptococcal disease, relapse had to be considered. On the other hand, CSF pleocytosis and contrast enhancement in MRI rendered immune reconstitution Table 1 Review of published cases with cryptococcal infections and IRS after initiation of highly active antiretroviral therapy. [5, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] ). In some cases, IRS may in fact unmask hitherto undiagnosed cryptococcosis [5] . Table 1 lists 26 published cases with cryptococcal infections that developed an IRS after initiation of highly active antiretroviral therapy [5, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . At the time when IRS developed the CD4 count increased in 21 patients > twofold and viral load decreased > 2log 10 copies/ml. Similar to our case, cryptococcal relapse could not be excluded in 20 patients who were therefore treated with antifungal therapy (Amphothericin B or high dose fluconazole) and secondary prophylaxis. In five patients, inflammatory treatment with steroids or non steroidal anti-inflammatory drugs was administered. All patients recovered from IRS. No significant correlation between initial signs and symptoms and the subsequent manifestation of IRS are apparent. IRS occurs in 10-30% of patients treated with ART and is associated a variety of microbial and non-microbial antigens. Often, initial CD4 cell counts are very low and briskly increase after starting ART [4] . Mycobacterial and cryptococcal antigens are frequently implicated in IRS. Indeed, a recent study found C. neoformans-related IRS in 30% of HIV-patients [6] . Compared to patients without IRS, patients with C. neoformans-related IRS had a lower HIV viral load, higher CD4 cell count, a higher CSF-opening pressure, higher mononuclear pleocytosis and lower cryptococcal antigen titer in the CSF. However, clinical signs and symptoms were not specific. Antifungal treatment was administered in all cases which emphasizes the clinical dilemma of suspected relapse versus IRS. Of note, neither relapse nor immune reconstitution was reported in a recent prospective study [1] . All patients in this study had optimally suppressed HIV viral loads of < 50 copies/ ml. One may speculate whether sub-optimally suppressed HIV replication in our patient may have preferentially infected and hence, deleted the Cryptococcus-specific CD4 cells which were activated by abundant antigen. The hypothesis may account for a true relapse despite CD4 cell counts > 200/µl and may explain the initial signs and symptoms in our patient. Possibly, discontinuation of secondary prophylaxis may bear a higher risk in sub-optimally suppressed HIV-patients.
